HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simona Martinotti Selected Research

Catalase

10/2014Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
11/2012Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simona Martinotti Research Topics

Disease

12Neoplasms (Cancer)
10/2022 - 12/2011
9Wounds and Injuries (Trauma)
01/2021 - 04/2011
8Malignant Mesothelioma
10/2022 - 12/2011
6Mesothelioma
10/2022 - 11/2012
3Inflammation (Inflammations)
12/2017 - 09/2012
2Burns
11/2017 - 01/2014
2Osteosarcoma (Osteogenic Sarcoma)
11/2016 - 01/2014
2Necrosis
11/2012 - 12/2011
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Plasma Cell Neoplasms
11/2020
1Multiple Myeloma
11/2020
1Infections
02/2019
1Acquired Immunodeficiency Syndrome (AIDS)
10/2018
1Weight Gain
02/2018
1Sepsis (Septicemia)
01/2015
1Breast Neoplasms (Breast Cancer)
10/2014

Drug/Important Bio-Agent (IBA)

5MMEIBA
10/2018 - 12/2011
4Biological ProductsIBA
04/2019 - 09/2012
3AsbestosIBA
10/2022 - 12/2011
3CalciumIBA
10/2020 - 01/2014
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2018 - 11/2012
3HMGB1 Protein (HMG1)IBA
11/2016 - 09/2012
2Pharmaceutical PreparationsIBA
09/2021 - 01/2013
2CytokinesIBA
01/2020 - 01/2015
2Peptides (Polypeptides)IBA
10/2018 - 01/2017
2CatalaseIBA
10/2014 - 11/2012
2GemcitabineFDA Link
01/2014 - 12/2011
1Aquaporin 6IBA
10/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1phenolic acidIBA
01/2021
1AntioxidantsIBA
01/2021
1FlavonoidsIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
11/2020
1Protein AggregatesIBA
11/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1IonsIBA
11/2019
1Ion Channels (Ion Channel)IBA
11/2019
1Propolis (Bee Bread)IBA
04/2019
1Anti-Bacterial Agents (Antibiotics)IBA
02/2019
1Local Anti-Infective Agents (Antiseptics)IBA
02/2019
1Endoplasmic Reticulum Chaperone BiPIBA
10/2018
1Molecular Chaperones (Chaperone, Molecular)IBA
10/2018
1hydroxyethyl methacrylate (HEMA)IBA
02/2018
1Collagenases (Collagenase)FDA Link
12/2017
1Proteins (Proteins, Gene)FDA Link
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016
1Z944IBA
10/2014
1MibefradilIBA
10/2014
1Ointments (Pastes)IBA
01/2014
1gallocatechol (epigallocatechin)IBA
01/2014
1Phosphotransferases (Kinase)IBA
01/2014
1Transforming Growth Factor beta (TGF-beta)IBA
01/2014
1Interleukin-8 (Interleukin 8)IBA
01/2013
1Interleukin-4 (Interleukin 4)IBA
01/2013
1InterleukinsIBA
01/2013
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2013
1Interleukin-6 (Interleukin 6)IBA
01/2013
1TeaIBA
11/2012
1Small Interfering RNA (siRNA)IBA
11/2012
1PolyphenolsIBA
11/2012
1Chemotactic FactorsIBA
09/2012
1Drug CombinationsIBA
12/2011
1Caspase 3 (Caspase-3)IBA
12/2011
1Oxidoreductases (Dehydrogenase)IBA
12/2011
1ElementsIBA
04/2011

Therapy/Procedure

7Therapeutics
09/2021 - 11/2012
1Drug Therapy (Chemotherapy)
10/2022
1Mediterranean Diet
01/2021
1Investigational Therapies (Experimental Therapy)
01/2014